Skip to main content
. 2021 Feb 6;21:133. doi: 10.1186/s12885-021-07869-7

Fig. 1.

Fig. 1

Flow diagram exhibiting the methods applied to identify objects to evaluate survival of cisplatin-paclitaxel chemotherapy plus BEV (CPB) versus cisplatin-paclitaxel chemotherapy alone (CPA) in postmenopausal women with previously untreated advanced cervical cancer (CC)